Miragen Therapeutics Inc - Strategy, SWOT and Corporate Finance Report

Miragen Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Miragen Therapeutics Inc (miRagen), formerly Signal Genetics Inc is a clinical stage biopharmaceutical company. The company discovers and develops novel RNA-based therapeutics, with a core focus on microRNAs and their roles in diseases. It focuses on hematological malignancies, neuro-degeneration, fibrosis and cardiovascular disease areas. Miragen lead pipeline products candidates are Cobomarsen (MRG-106), an inhibitor of microRNA-155 for treating blood cancers; Remlarsen (MRG-201), a replacement for miR-29 for treating or preventing pathologic fibrosis and MRG-110, an inhibitor of microRNA-92 for treating ischemic conditions. Miragen is headquartered in Boulder, Colorado, the US.

Scope

  • Detailed information on Miragen Therapeutics Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Miragen Therapeutics Inc in the form of a SWOT analysis
  • An in-depth view of the business model of Miragen Therapeutics Inc including a breakdown and examination of key business segments
  • News about Miragen Therapeutics Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Miragen Therapeutics Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Miragen Therapeutics Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Miragen Therapeutics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Regulus Therapeutics Inc

Novartis International AG

Mylan Pharmaceuticals Inc

Merck & Co Inc

Ionis Pharmaceuticals Inc

InteRNA Technologies BV

F. Hoffmann-La Roche Ltd

Dicerna Pharmaceuticals ...

Regulus Therapeutics Inc

Novartis International AG

Mylan Pharmaceuticals Inc

Merck & Co Inc

Ionis Pharmaceuticals Inc

InteRNA Technologies BV

F. Hoffmann-La Roche Ltd

Dicerna Pharmaceuticals Inc

Celgene Corp

Bristol-Myers Squibb Co

Arrowhead Pharmaceuticals Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Miragen Therapeutics Inc - Key Facts

Miragen ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Miragen Therapeutics Inc - Key Facts

Miragen Therapeutics Inc - Key Employees

Miragen Therapeutics Inc - Key Employee Biographies

Miragen Therapeutics Inc - Major Products and Services

Miragen Therapeutics Inc - History

Miragen Therapeutics Inc - Company Statement

Miragen Therapeutics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Miragen Therapeutics Inc - Business Description

R&D Overview

Miragen Therapeutics Inc - Corporate Strategy

Miragen Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Miragen Therapeutics Inc - Strengths

Miragen Therapeutics Inc - Weaknesses

Miragen Therapeutics Inc - Opportunities

Miragen Therapeutics Inc - Threats

Miragen Therapeutics Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Miragen Therapeutics Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 08, 2019: miRagen announces first quarter 2019 financial results and provides corporate update

Mar 13, 2019: miRagen announces fourth quarter and full year 2018 financial results and provides 2019 outlook

Dec 05, 2018: miRagen Therapeutics announces board of director evolution and appointment of new chairman

Nov 07, 2018: miRagen Therapeutics reports third quarter 2018 financial results and provides corporate update

Aug 07, 2018: miRagen Therapeutics announces second quarter 2018 financial results

May 09, 2018: miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

Mar 14, 2018: miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

Jan 05, 2018: miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Miragen Therapeutics Inc, Key Facts

Miragen Therapeutics Inc, Key Employees

Miragen Therapeutics Inc, Key Employee Biographies

Miragen Therapeutics Inc, Major Products and ...

List of Tables

Miragen Therapeutics Inc, Key Facts

Miragen Therapeutics Inc, Key Employees

Miragen Therapeutics Inc, Key Employee Biographies

Miragen Therapeutics Inc, Major Products and Services

Miragen Therapeutics Inc, History

Miragen Therapeutics Inc, Subsidiaries

Miragen Therapeutics Inc, Key Competitors

Miragen Therapeutics Inc, Ratios based on current share price

Miragen Therapeutics Inc, Annual Ratios

Miragen Therapeutics Inc, Annual Ratios (Cont...1)

Miragen Therapeutics Inc, Interim Ratios

Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Miragen Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Miragen Therapeutics Inc, Performance Chart (2014 - 2018)

Miragen Therapeutics Inc, Ratio Charts

Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2013 ...

List of Figures

Miragen Therapeutics Inc, Performance Chart (2014 - 2018)

Miragen Therapeutics Inc, Ratio Charts

Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Miragen Therapeutics Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports